LENZ Therapeutics
Tracked across 1 events · 6 articles · First seen Sep 01, 2026 · Last active Sep 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Pomerantz LLP announced it is investigating claims on behalf of investors of LENZ Therapeutics, Inc. (Nasdaq: LENZ) concerning whether the company and certain officers and/or directors engaged in securities fraud or other unlawful business practices.…
Impact: LENZ Therapeutics is the subject of the investigation and experienced a sharp stock price decline following its Q2 results and the downgrade. The company faces potential securities fraud claims and reputational damage.
Sep 01, 2026 · 6 articles
90
Bank of America downgraded stock LENZ TherapeuticsPomerantz investigates...
80
LENZ Therapeutics reported financial resultsPomerantz investigates...
70
Pomerantz LLP investigating securities fraud LENZ TherapeuticsPomerantz investigates...
ERGEN INTELLIGENCE
Track LENZ Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard